Argenica Therapeutics Ltd (AGN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.602x

Based on the latest financial reports, Argenica Therapeutics Ltd (AGN) has a cash flow conversion efficiency ratio of -1.602x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.51 Million ≈ $-3.90 Million USD) by net assets (AU$3.44 Million ≈ $2.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AGN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Argenica Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Argenica Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Argenica Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argenica Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kalgoorlie Gold Mining Ltd AU:KAL	-0.023x
Caring Brands, Inc. Common Stock NASDAQ:CABR	0.275x
Zhibao Technology Inc. Class A Ordinary Shares NASDAQ:ZBAO	-0.244x
Merchant House International Ltd AU:MHI	-0.197x
Lion Metal Works Tbk JK:LION	0.029x
AUX Resources Corporation V:AUX	-0.300x
SACCHERIA F.LLI FRANCES. F:YV1	N/A
Tarjar Xairo Socimi SA MC:YTAR	-0.062x

Annual Cash Flow Conversion Efficiency for Argenica Therapeutics Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Argenica Therapeutics Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Argenica Therapeutics Ltd (AGN) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$7.24 Million ≈ $5.12 Million	AU$-5.70 Million ≈ $-4.04 Million	-0.788x	-117.29%
2023-12-31	AU$13.95 Million ≈ $9.87 Million	AU$-5.06 Million ≈ $-3.58 Million	-0.363x	+15.74%
2022-12-31	AU$7.67 Million ≈ $5.42 Million	AU$-3.30 Million ≈ $-2.34 Million	-0.430x	-6.38%
2021-12-31	AU$8.31 Million ≈ $5.88 Million	AU$-3.36 Million ≈ $-2.38 Million	-0.405x	-164.77%
2020-12-31	AU$6.85 Million ≈ $4.84 Million	AU$-1.05 Million ≈ $-740.40K	-0.153x	+95.22%
2019-12-31	AU$18.40K ≈ $13.02K	AU$-58.82K ≈ $-41.62K	-3.197x	--

About Argenica Therapeutics Ltd

AU:AGN Australia Biotechnology

Market Cap

$10.00 Million

AU$14.13 Million AUD

Market Cap Rank

#27049 Global

#1319 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.11 - AU$0.76

All Time High

AU$0.99